Abstracts tagged "metabolic syndrome and rheumatoid arthritis (RA)"

Abstract Number: 1542 • 2016 ACR/ARHP Annual Meeting
Metabolic Syndrome and Cardiovascular Risk Factors in Brazilian Patients with Established Rheumatoid Arthritis
Maria Fernanda Guimaraes¹, Kirla Gomes², Susana Krampe³, Carla Machado⁴, Claiton Brenol⁵, Carlos Ewerton Rodrigues⁶ and Adriana Kakehasi⁷, ¹Rheumatology, Hospital das Clínicas UFMG, Belo Horizonte, Brazil, ²Rheumatology, Hospital Geral Fortaleza, Fortaleza, Brazil, ³Hospital de Clínicas de Porto Alegre /UFRGS, Porto Alegre, Brazil, ⁴Faculdade de Medicina UFMG, Belo Horizonte, Brazil, ⁵Rua Cabral, 764 – Apto 302, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, ⁶Hospital Geral Fortaleza, Fortaleza, Brazil, ⁷Rheumatology, Hospital das Clínicas /UFMG, Belo Horizonte, Brazil
Background/Purpose: rheumatoid arthritis (RA) has been stablished as an independent risk factor for cardiovascular diseases. Metabolic syndrome (MS) may provide additional link between accelarated…
Abstract Number: 1544 • 2016 ACR/ARHP Annual Meeting
Serum Omentin-1 Levels and Metabolic Syndrome in Women with Rheumatoid Arthritis
Alejandra Flores-Chavez^1,2, Edsaul Emilio Perez-Guerrero^3,4, Melissa Ramirez-Villafaña^5,6, Xochitl Trujillo⁷, Arnulfo Hernan Nava-Zavala⁸, Teresa Arcelia Garcia-Cobian⁹, Miriam Fabiola Alcaraz-Lopez¹⁰, Mario Salazar-Paramo¹¹, Ernesto German Cardona-Muñoz¹², Silvia Elena Totsuka-Sutto¹², Laura del Carmen Gonzalez-Lopez⁵ and Jorge Ivan Gamez-Nava¹³, ¹Unidad de Investigación Biomédica 02 (Unidad de Investigación en Epidemiología Clínica), UMAE, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Jalisco, Mexico, ²Doctorado en Ciencias Médicas, Universidad de Colima, Colima, Mexico, ³Unidad de Investigación Biomédica 02 (Unidad de Investigación en Epidemiología Clínica), UMAE, Hospital de Especialidades Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Jalisco, Mexico, ⁴Doctorado en Farmacología, Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Jalisco, Mexico, ⁵Departamento Medicina Interna-Reumatología, Instituto Mexicano del Seguro Social, Hospital General Regional 110, Jalisco, Mexico, ⁶Doctorado en Ciencias Médicas, Universidad de Colima, Jalisco, Mexico, ⁷Centro Universitario de Investigación Biomédica, Universidad de Colima, Colima, Mexico, ⁸Unidad de Investigación Biomédica 02 (Unidad de Investigación en Epidemiología Clínica), UMAE, Hospital de Especialidades Centro Médico Nacional de Occidente, IMSS, Jalisco, Mexico, ⁹Unidad de Investigación Cardiovascular, Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Jalisco, Mexico, ¹⁰Departamento Medicina Interna-Reumatología, Instituto Mexicano del Seguro Social, Hospital General Regional 45, Jalisco, Mexico, ¹¹División de Investigación en Salud, Unidad Médica de Alta Especialidad, Hospital de Especialidades Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Jalisco, Mexico, ¹²Departamento de Fisiología, Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Jalisco, Mexico, ¹³Unidad de Investigación Biomédica 02 (Unidad de Investigacion en Epidemiología Clínica), UMAE, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituo Mexicano del Seguro Social, Guadalajara, Mexico
Background/Purpose: Metabolic syndrome (MS) is a common comorbidity in patients with rheumatoid arthritis (RA). Several adipokines have been implied in the pathogenesis of MS on…
Abstract Number: 1584 • 2015 ACR/ARHP Annual Meeting
Metabolic Syndrome Is Associated with Disease Activity in Patients with Rheumatoid Arthritis: A Prospective Cohort Study
Pongchirat Tantayakom¹, Ajchara Koolvisoot¹, Emvalee Arromdee¹, Praveena Chiowchanwisawakit¹, Chayawee Muangchan¹ and Wanruchada Katchamart², ¹Division of Rheumatology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, ²Medicine, Division of Rheumatology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Background/Purpose: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease involving articular and extra-articular systems, including cardiovascular (CVS), respiratory, as well as hematologic systems, etc.…
Abstract Number: 1371 • 2014 ACR/ARHP Annual Meeting
Impact of Metabolic Syndrome (MetS) on Rheumatoid Arthritis Disease Activity
Federico Parra-Salcedo¹, Irazú Contreras-Yáñez², Daniel Elías-López³, Carlos A. Aguilar-Salinas³ and Virginia Pascual-Ramos⁴, ¹Internal Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, Mexico, ²Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, ³Endocrinology and Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán., Mexico City, Mexico, ⁴Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
Background/Purpose The purpose of the study was to describe prevalence and components (c) of MetS in a cohort of early RA, to compare it with…
Abstract Number: 1261 • 2012 ACR/ARHP Annual Meeting
Epicardial Adipose Tissue Is Associated with Cardiometabolic Risk and the Metabolic Syndrome in Patients with Rheumatoid Arthritis
Michelle J. Ormseth¹, Aliza Lipson², Nikolaos Alexopoulos³, Gregory R. Hartlage³, Annette M. Oeser⁴, Aihua Bian⁴, Tebeb Gebretsadik⁵, Ayumi Shintani⁴, Paolo Raggi⁶ and C. Michael Stein⁷, ¹Rheumatology, Vanderbilt Medical Center, Nashville, TN, ²Rheumatology, Emory University, Atlanta, GA, ³Emory University, Atlanta, GA, ⁴Vanderbilt Medical Center, Nashville, TN, ⁵Biostatistics, Vanderbilt University, Nashville, TN, ⁶University of Alberta, Edmonton, AB, Canada, ⁷School of Medicine, Division of Clinical Pharmacology, Vanderbilt Medical Center, Nashville, TN
Background/Purpose: Patients with rheumatoid arthritis (RA) have increased coronary atherosclerosis and this may be related to their increased prevalence of visceral adiposity, insulin resistance, and…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].